Content Marketing InstituteContent directory

Health

6.  Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases? (1)

Category: Type Topic: Health
6.  Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases? (1)

Image: free stock via Unsplash · topic Health

Am J Clin Nutr . 2009;89(5):1607S-1612S.

7 . Tonstad S, Stewart K, Oda K, et al. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis . 2013;23(4):292-299.

8 . Bradbury KE, Crowe FL, Appleby PN, et al. Serum concentrations of cholesterol, apolipoprotein A-I and apolipoprotein B in a total of 1694 meat-eaters, fish-eaters, vegetarians and vegans. Eur J Clin Nutr . 2014;68(2):178-183.

9 . Yao B, Fang H, Xu W, et al. Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies. Eur J Epidemiol . 2014;29(2):79-88.

10 . InterAct Consortium. Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-InterAct Study and a meta-analysis of prospective studies. Diabetologia . 2015;58(7):1394-1408.

11 . Krishnan S, Rosenberg L, Singer M, et al. Glycemic Index, Glycemic Load, and Cereal Fiber Intake and Risk of Type 2 Diabetes in US Black Women. Arch Intern Med . 2007;167(21):2304.

12 . Schulze MB, Schulz M, Heidemann C, et al. Fiber and Magnesium Intake and Incidence of Type 2 Diabetes. Arch Intern Med . 2007;167(9):956.

13 . Bozzetto L, Costabile G, Pepa G Della, et al. Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk. Nutrients . 2018;10:943.

14 . Silva FM, Kramer CK, de Almeida JC, et al. Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev . 2013;71(12):790-801.

15 . McIntosh M, Miller C. A diet containing food rich in soluble and insoluble fiber improves glycemic control and reduces hyperlipidemia among patients with type 2 diabetes mellitus. Nutr Rev . 2001;59(2):52-55.

16 . Aydin Ö, Nieuwdorp M, Gerdes V. The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes. Genetics . 2018;18(8):55.

17 . Islam MA, Alam F, Solayman M, et al. Dietary Phytochemicals: Natural Swords Combating Inflammation and Oxidation-Mediated Degenerative Diseases. Oxid Med Cell Longev . 2016;2016:5137431.

18 . Aryaeian N, Sedehi SK, Arablou T. Polyphenols and their effects on diabetes management: A review. Med J Islam Repub Iran . 2017;31:134.

19 . Silveira AC, Dias JP, Santos VM, et al. The action of polyphenols in Diabetes Mellitus and Alzheimer’s disease: a common agent for overlapping pathologies. Curr Neuropharmacol . 2018;16.

20 . Singh H, Venkatesan V. Treatment of ‘Diabesity’: Beyond Pharmacotherapy. Curr Drug Targets . 2018;19(14):1672-1682.

21 . Carrera-Quintanar L, López Roa RI, Quintero-Fabián S, et al. Phytochemicals That Influence Gut Microbiota as Prophylactics and for the Treatment of Obesity and Inflammatory Diseases. Mediators Inflamm. 2018;2018:9734845.

22 . Ahangarpour A, Sayahi M, Sayahi M. The antidiabetic and antioxidant properties of some phenolic phytochemicals: A review study. Diabetes Metab Syndr Clin Res Rev . 2019;13(1):854-857.

23 . Silva B, Oliveira P, Casal S, et al. Promising Potential of Dietary (Poly)Phenolic Compounds in the Prevention and Treatment of Diabetes Mellitus. Curr Med Chem . 2017;24(4):334-354.

24 . Leiherer A, Mündlein A, Drexel H. Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vascul Pharmacol . 2013;58(1-2):3-20.

25 . Zhang D-W, Fu M, Gao S-H, Liu J-L. Curcumin and Diabetes: A Systematic Review. Evidence-Based Complement Altern Med . 2013;2013:16.

26 . Sanati S, Razavi BM, Hosseinzadeh H. A review of the effects of Capsicum annuum L. and its constituent, capsaicin, in metabolic syndrome. Iran J Basic Med Sci . 2018;21(5):439-448.

27 . Zhu J, Chen H, Song Z, et al. Effects of Ginger (Zingiber officinale Roscoe) on Type 2 Diabetes Mellitus and Components of the Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med . 2018;2018:5692962.

28 . Fernando WMADB, Somaratne G, Goozee KG, et al. Diabetes and Alzheimer’s Disease: Can Tea Phytochemicals Play a Role in Prevention? J Alzheimer’s Dis . 2017;59(2):481-501.

29 . Fu Q-Y, Li Q-S, Lin X-M, et al. Antidiabetic Effects of Tea. Molecules . 2017;22(5):849.

30 . Szkudelski T, Szkudelska K. Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta - Mol Basis Dis . 2015;1852(6):1145-1154.

31 . Öztürk E, Arslan AKK, Yerer MB, Bishayee A. Resveratrol and diabetes: A critical review of clinical studies. Biomed Pharmacother . 2017;95:230-234.

32 . Behloul N, Wu G. Genistein: A promising therapeutic agent for obesity and diabetes treatment. Eur J Pharmacol . 2013;698(1-3):31-38.

33 . Chen S, Jiang H, Wu X, Fang J. Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes. Mediators Inflamm . 2016;2016:9340637.

34 . Link LB, Potter JD. Raw versus cooked vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev . 2004;13(9):1422-1435.

35 . Roohbakhsh A, Karimi G, Iranshahi M. Carotenoids in the treatment of diabetes mellitus and its complications: A mechanistic review. Biomed Pharmacother . 2017;91:31-42.

36 . Manna P, Jain SK. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metab Syndr Relat Disord . 2015;13(10):423-444.

37 . Yoo JY, Kim SS. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients . 2016;8(3):173.

38 . Barengolts E. Gut microbiota, prebiotics, probiotics, and synbiotics in management of obesity and prediabetes: review of randomized controlled trials. Endocr Pract . 2016;22(10):1224-1234.

39 . Sáez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, et al. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: A review of human clinical trials. Int J Mol Sci . 2016;17(6).

40 . Baker EJ, Miles EA, Burdge GC, et al. Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Prog Lipid Res . 2016;64:30-56.

41 . Molfino A, Amabile MI, Monti M, Muscaritoli M. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both? Oxid Med Cell Longev . 2017;2017:5987082.

42 . Bhaswant M, Poudyal H, Brown L. Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsaturated fatty acids. J Nutr Biochem . 2015;26(6):571-584.

43 . Trautwein EA, Koppenol WP, De Jong A, et al. Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes; a randomized, double-blind, placebo-controlled study. Nutr Diabetes . 2018;8:30.

44 . Vilahur G, Ben-Aicha S, Diaz E, et al. Phytosterols and inflammation. Curr Med Chem . 2018; June 22 (e-pub ahead of print).

45 . Derdemezis CS, Filippatos TD, Mikhailidis DP, Elisaf MS. Review Article: Effects of Plant Sterols and Stanols Beyond Low-Density Lipoprotein Cholesterol Lowering. J Cardiovasc Pharmacol Ther . 2010;15(2):120-134.

46 . Cooper AJM, Sharp SJ, Luben RN, et al. The association between a biomarker score for fruit and vegetable intake and incident type 2 diabetes: the EPIC-Norfolk study. Eur J Clin Nutr . 2015;69(4):449-454.

47 . Liang J, Zhang Y, Xue A, et al. Association between fruit, vegetable, seafood, and dairy intake and a reduction in the prevalence of type 2 diabetes in Qingdao, China. Asia Pac J Clin Nutr . 2017;26(2):255-261.

48 . Li M, Fan Y, Zhang X, et al. Fruit and vegetable intake and risk of type 2 diabetes mellitus: meta-analysis of prospective cohort studies. BMJ Open . 2014;4(11):e005497.

49 . Schwingshackl L, Hoffmann G, Lampousi A-M, et al. Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol . 2017;32(5):363-375.

50 . Clark JL, Taylor CG, Zahradka P. Rebelling against the (Insulin) Resistance: A Review of the Proposed Insulin-Sensitizing Actions of Soybeans, Chickpeas, and Their Bioactive Compounds. Nutrients . 2018;10(4).

51 . Agrawal S, Ebrahim S. Association between legume intake and self-reported diabetes among adult men and women in India. BMC Public Health . 2013;13(1):1.

52 . Villegas R, Gao Y-T, Yang G, et al. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women’s Health Study. Am J Clin Nutr . 2008;87(1):162-167.

53 . Tian S, Xu Q, Jiang R, Het al. Dietary Protein Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cohort Studies. Nutrients . 2017;9(9).

54 . Aune D, Norat T, Romundstad P, Vatten LJ. Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose, response meta-analysis of cohort studies. Eur J Epidemiol . 2013;28(11):845-858.

55 . Ye EQ, Chacko SA, Chou EL, et al. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr . 2012;142(7):1304-1313.

56 . Kyrø C, Tjønneland A, Overvad K, et al. Higher whole-grain intake is associated with lower risk of type 2 diabetes among middle-aged men and women: The Danish Diet, Cancer, and Health Cohort. J Nutr . 2018;148(9):1434-1444.

57 . Asghari G, Ghorbani Z, Mirmiran P, Azizi F. Nut consumption is associated with lower incidence of type 2 diabetes: The Tehran Lipid and Glucose Study. Diabetes Metab . 2017;43(1):18-24.

58 . Luo C, Zhang Y, Ding Y, et al. Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis. Am J Clin Nutr . 2014;100(1):256-269.

59 . Vuksan V, Choleva L, Jovanovski E, et al. Comparison of flax (Linum usitatissimum) and Salbachia (Salvia hispanica L.) seeds on postprandial glycemia and satiety in healthy individuals: a randomized, controlled, crossover study. Eur J Clin Nutr . 2017;71(2):234-238.

60 . Sylvia H. Ley, Osama Hamdy, V. Mohan FBH. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet . 2014;383(9933):1999-2007.

61 . Dam RM Van, Seidell JC. Carbohydrate intake and obesity. Eur J Clin Nutr . 2007;61. Suppl 1:S75-99.

62 . Buyken AE, Flood V, Empson M, et al. Carbohydrate nutrition and inflammatory disease mortality in older adults. Am J Clin Nutr . 2010;3:634-643.

63 . Myles IA. Fast Food Fever: Reviewing the impacts of the western diet on immunity. Nutrition Journal . 2014:13;61.

64 . DiNicolantonio JJ, Mehta V, Onkaramurthy N, O’Keefe JH. Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity. Prog Cardiovasc Dis . 2018;61(1):3-9.

65 . Stanhope KL. Sugar consumption, metabolic disease and obesity: The state of the controversy HHS Public Access. Crit Rev Clin Lab Sci . 2016;53(1):52-67.

66 . Bhardwaj B, O’keefe EL, O’keefe JH. Death by Carbs: Added sugars and refined carbohydrates cause diabetes and cardiovascular disease in asian indians. Mo Med . 2016;113(5):395-400.

67 . Asgari-Taee F, Zerafati-Shoae N, Dehghani M, Sadeghi M, Baradaran HR, Jazayeri S. Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Nutr . 2018. (e-pub ahead of print)

68 . Liu B, Sun Y, Snetselaar LG, et al. Association between plasma trans-fatty acid concentrations and diabetes in a nationally representative sample of US adults. J Diabetes . 2018;10(8):653-664.

69 . Dorfman SE, Laurent D, Gounarides JS, et al. Metabolic implications of dietary trans-fatty acids. Obesity . 2009;17(6):1200-1207.

70 . Tsutsui W, Fujioka Y. Is the association between dietary trans fatty acids and insulin resistance remarkable in Japan? J Atheroscler Thromb . 2017;24:1199-1201.